149 related articles for article (PubMed ID: 30317211)
1. Scleromyxoedema: the importance of physical examination.
Pipa S; Sá J; Mondragão A; Marinho A
BMJ Case Rep; 2018 Oct; 2018():. PubMed ID: 30317211
[No Abstract] [Full Text] [Related]
2. Uncommon Presentation of Scleromyxoedema with a Distribution Pattern Mimicking a Photodermatosis.
Kirchberger MC; Sticherling M; Erdmann M
Acta Derm Venereol; 2017 Aug; 97(8):979-980. PubMed ID: 28421236
[No Abstract] [Full Text] [Related]
3. Scleromyxoedema: clinical follow-up after successful treatment with high-dose immunoglobulins reveals different long-term outcomes.
Bidier M; Zschoche C; Gholam P; Enk AH; Hadaschik EN
Acta Derm Venereol; 2012 Jul; 92(4):408-9. PubMed ID: 22278389
[No Abstract] [Full Text] [Related]
4. Intravenous gammaglobulin and thalidomide may be an effective therapeutic combination in refractory scleromyxedema: case report and discussion of the literature.
Efthimiou P; Blanco M
Semin Arthritis Rheum; 2008 Dec; 38(3):188-94. PubMed ID: 18221985
[TBL] [Abstract][Full Text] [Related]
5. [Clinical characteristics, outcome of scleromyxoedema: a retrospective multicentre study].
Le Moigne M; Mazereeuw-Hautier J; Bonnetblanc JM; Astudillo L; D'Incan M; Bessis D; Thomas L; Debarbieux S; Ammoury A; Lamant L; Paul C
Ann Dermatol Venereol; 2010 Dec; 137(12):782-8. PubMed ID: 21134580
[TBL] [Abstract][Full Text] [Related]
6. Scleromyxedema.
Bogner RR; Wetter DA; Dingli D
Intern Med; 2014; 53(21):2561-2. PubMed ID: 25366027
[No Abstract] [Full Text] [Related]
7. An unusual presentation of scleromyxedema as inflammatory myopathy.
Vysakha KV; Poyuran R; Nair SS; Nair M
Acta Myol; 2019 Mar; 38(1):13-16. PubMed ID: 31309176
[TBL] [Abstract][Full Text] [Related]
8. Scleromyxedema: successful treatment with thalidomide in two patients.
Amini-Adle M; Thieulent N; Dalle S; Balme B; Thomas L
Dermatology; 2007; 214(1):58-60. PubMed ID: 17191049
[TBL] [Abstract][Full Text] [Related]
9. Rare case of infiltrative cardiomyopathy secondary to scleromyxoedema.
Khandkar C; Vaidya K; Penglase R; Cai K; Shin JS; Hunyor I; Keech A; McGill N
Intern Med J; 2020 Jan; 50(1):127-128. PubMed ID: 31943623
[No Abstract] [Full Text] [Related]
10. Scleromyxedema--thalidomide therapy.
Martins A; Paiva Lopes MJ; Tavares Belo R; Rodrigues JC
J Eur Acad Dermatol Venereol; 2008 May; 22(5):622-4. PubMed ID: 18312333
[No Abstract] [Full Text] [Related]
11. Combination of intravenous immunoglobulins and lenalidomide in the treatment of scleromyxedema.
Brunet-Possenti F; Hermine O; Marinho E; Crickx B; Descamps V
J Am Acad Dermatol; 2013 Aug; 69(2):319-20. PubMed ID: 23866873
[No Abstract] [Full Text] [Related]
12. Scleromyxedema in a 21 year old female patient with acute lymphoblastic leukemia: a case report.
Rabee H; Tayem L; Gharbeyah M; Abugaber D
BMC Dermatol; 2020 Dec; 20(1):18. PubMed ID: 33276772
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy of intravenous immunoglobulin in the treatment of scleromyxoedema].
Sillard L; Passeron T; Cardot-Leccia N; Perrin C; Lacour JP; Ortonne JP
Ann Dermatol Venereol; 2010 Jan; 137(1):48-52. PubMed ID: 20110069
[TBL] [Abstract][Full Text] [Related]
14. Thalidomide and dexamethasone followed by autologous stem cell transplantation for scleromyxoedema.
Bos R; de Waal EG; Kuiper H; Hazenberg BP; Vellenga E
Rheumatology (Oxford); 2011 Oct; 50(10):1925-6. PubMed ID: 21719421
[No Abstract] [Full Text] [Related]
15. Vincristine, idarubicin, dexamethasone and thalidomide in scleromyxoedema.
Laimer M; Namberger K; Massone C; Koller J; Emberger M; Pleyer L; Hintner H; Greil R
Acta Derm Venereol; 2009 Nov; 89(6):631-5. PubMed ID: 19997697
[TBL] [Abstract][Full Text] [Related]
16. Scleromyxedema vs scleredema: a diagnostic challenge.
Conde Fernandes I; Sanches M; Velho G; Lobo I; Alves R; Selores M
Eur J Dermatol; 2011; 21(5):822-3. PubMed ID: 21771713
[No Abstract] [Full Text] [Related]
17. Clinical features of scleromyxoedema in an Afro-Caribbean man.
Ufodiama CE; Tynes G; Unwala R
BMJ Case Rep; 2019 Jan; 12(1):. PubMed ID: 30665930
[No Abstract] [Full Text] [Related]
18. Scleromyxoedema due to a plasma cell neoplasm: rapid remission with bortezomib, thalidomide and dexamethasone.
Yeung CK; Loong F; Kwong YL
Br J Haematol; 2012 May; 157(4):411. PubMed ID: 22429092
[No Abstract] [Full Text] [Related]
19. Managing scleromyxedema with intravenous immunoglobulin: acute worsening of scleromyxedema with biclonal gammopathy.
Manousaridis I; Loeser C; Goerdt S; Hassel JC
Acta Dermatovenerol Alp Pannonica Adriat; 2010 Dec; 19(4):15-9. PubMed ID: 21390475
[TBL] [Abstract][Full Text] [Related]
20. [Scleromyxedema].
Kukova G; Bruch-Gerharz D; Gensch K; Ruzicka T; Reifenberger J
Hautarzt; 2006 Apr; 57(4):326-7. PubMed ID: 16523272
[No Abstract] [Full Text] [Related]
[Next] [New Search]
